Embedded Files
Pharmacological Inhibition of CBP/p300 Blocks ERα Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer. Cancers, 2021.
Pharmacological Inhibition of CBP/p300 Blocks ERα Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer. Cancers, 2021.
Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance. Cancer Discovery, 2021.
Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance. Cancer Discovery, 2021.
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors. Nature Cancer, 2025.
CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors. Nature Cancer, 2025.
Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program. Cancer Discovery, 2023.
Dimeric p53 Mutant Elicits Unique Tumor-Suppressive Activities through an Altered Metabolic Program. Cancer Discovery, 2023.
Page updated
Google Sites
Report abuse